Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF
Por um escritor misterioso
Descrição
Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference
News - Physiogenex
Cardiomedex
Frontiers Microvascular Dysfunction in Heart Failure With
Physiogenex and Cardiomedex to present their original preclinical
Natália Breyner - Scientist/Project Manager/R&D at Physiogenex
François Briand en LinkedIn: #ksns #nash #obesity #drugdevelopment
François Briand sur LinkedIn : #esccongress #esccongress #obesity
Elafibranor improves diet-induced nonalcoholic steatohepatitis
Differential Pathophysiological Mechanisms in Heart Failure With a
Heart Failure With Preserved Ejection Fraction
Caroline Dubroca sur LinkedIn : APASL 2022 - Physiogenex e-poster
PDF) Elafibranor improves diet-induced nonalcoholic
de
por adulto (o preço varia de acordo com o tamanho do grupo)
